Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

119
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
119
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

71
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
71
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

93
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
93
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

95
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
95
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

91
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
91
Angina IV: Management01:26

Angina IV: Management

101
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
101

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prognostic value of aortic height and size indices in veterans with ascending aortic aneurysm.

The Journal of thoracic and cardiovascular surgery·2026
Same author

Clamp On vs Off Impact of Distal Anastomotic Technique During Ascending Aortic Replacement in Acute Type A Aortic Dissection: IRAD Insights.

Interdisciplinary cardiovascular and thoracic surgery·2026
Same author

Cardiopulmonary bypass is safe and effective support for concomitant high-risk percutaneous coronary intervention and transcatheter aortic valve replacement.

The Journal of invasive cardiology·2026
Same author

CT-based visualization of aortic valve morphology: from 3D energy-integrating CT to 4D photon counting CT.

Frontiers in cardiovascular medicine·2026
Same author

Completed and ongoing trials in minimally invasive cardiac surgery coronary surgery.

Current opinion in cardiology·2025
Same author

Genome sequencing is critical for forecasting outcomes following congenital cardiac surgery.

Nature communications·2025

Related Experiment Video

Updated: Nov 7, 2025

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
08:50

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement

Published on: March 26, 2018

11.9K

Current Therapeutic Options in Aortic Stenosis.

Marko T Boskovski1, Thomas G Gleason1

  • 1Division of Cardiac Surgery, Brigham and Women's Hospital, Boston, MA.

Circulation Research
|April 29, 2021
PubMed
Summary
This summary is machine-generated.

Aortic stenosis, a common valve disease, has seen major advancements in treatment. Transcatheter aortic valve replacement is now a preferred option for many patients, especially the elderly.

Keywords:
aortic valveaortic valve stenosiscoronary artery diseaseheart diseasetranscatheter aortic valve replacement

More Related Videos

Author Spotlight: Development of a Minimally Invasive Large-Animal Model for Reliable and Reproducible Cardiovascular Research
06:51

Author Spotlight: Development of a Minimally Invasive Large-Animal Model for Reliable and Reproducible Cardiovascular Research

Published on: October 20, 2023

1.3K
Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
12:17

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots

Published on: May 21, 2017

11.6K

Related Experiment Videos

Last Updated: Nov 7, 2025

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
08:50

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement

Published on: March 26, 2018

11.9K
Author Spotlight: Development of a Minimally Invasive Large-Animal Model for Reliable and Reproducible Cardiovascular Research
06:51

Author Spotlight: Development of a Minimally Invasive Large-Animal Model for Reliable and Reproducible Cardiovascular Research

Published on: October 20, 2023

1.3K
Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
12:17

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots

Published on: May 21, 2017

11.6K

Area of Science:

  • Cardiology
  • Valvular Heart Disease
  • Medical Device Technology

Background:

  • Aortic stenosis is the most prevalent valvular heart disease necessitating valve replacement.
  • Therapeutic interventions for aortic stenosis have evolved significantly since the 1960s.
  • Transcatheter aortic valve replacement (TAVR) has revolutionized treatment over the past two decades.

Purpose of the Study:

  • To review the pathophysiology of aortic stenosis.
  • To outline the clinical presentation and diagnostic methods for aortic stenosis.
  • To discuss current indications and therapeutic strategies for aortic stenosis.

Main Methods:

  • Literature review of aortic stenosis pathophysiology.
  • Analysis of diagnostic criteria and clinical presentation.
  • Evaluation of evolving valve replacement therapies, including TAVR.

Main Results:

  • Aortic stenosis management has shifted towards less invasive approaches.
  • Transcatheter aortic valve replacement is now a primary treatment for many patients, particularly the elderly.
  • Significant progress in valve replacement technology has improved patient outcomes.

Conclusions:

  • Transcatheter aortic valve replacement represents a paradigm shift in managing aortic stenosis.
  • Understanding the pathophysiology, diagnosis, and evolving treatment options is crucial for optimal patient care.
  • Current therapeutic options offer improved quality of life and survival for patients with aortic stenosis.